An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

…, HR Collard, JJ Egan, FJ Martinez, J Behr… - American journal of …, 2011 - atsjournals.org
This document is an international evidence-based guideline on the diagnosis and management
of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic …

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study

…, ML Wilsher, KM Antoniou, J Behr… - European …, 2017 - Eur Respiratory Soc
We conducted an international study of idiopathic pulmonary fibrosis (IPF) diagnosis among
a large group of physicians and compared their diagnostic performance to a panel of IPF …

Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline

…, CJ Ryerson, DJ Lederer, J Behr… - American journal of …, 2018 - atsjournals.org
Background: This document provides clinical recommendations for the diagnosis of
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …

An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline

…, Y Zhang, CAC Garcia, A Azuma, J Behr… - American journal of …, 2015 - atsjournals.org
Background: This document updates the American Thoracic Society/European Respiratory
Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on …

[HTML][HTML] High-dose acetylcysteine in idiopathic pulmonary fibrosis

M Demedts, J Behr, R Buhl, U Costabel… - … England Journal of …, 2005 - Mass Medical Soc
Background Idiopathic pulmonary fibrosis is a chronic progressive disorder with a poor
prognosis. Methods We conducted a double-blind, randomized, placebo-controlled multicenter …

Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report

…, TM Maher, AU Wells, KM Antoniou, J Behr… - American journal of …, 2016 - atsjournals.org
Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically
significant, respiratory deterioration of unidentifiable cause. The objective of this …

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry

…, M Halank, M Held, C Grohé, TJ Lange, J Behr… - International journal of …, 2013 - Elsevier
Background Originally reported to occur predominantly in younger women, idiopathic pulmonary
arterial hypertension (IPAH) is increasingly diagnosed in elderly patients. We aimed to …

BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis

…, I Leconte, A Morganti, S Roux, J Behr - American journal of …, 2011 - atsjournals.org
Rationale: A previous trial of bosentan in idiopathic pulmonary fibrosis (IPF) showed a trend
to delayed IPF worsening or death. Also, improvements in some measures of dyspnea and …

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial

G Raghu, J Behr, KK Brown, JJ Egan… - Annals of internal …, 2013 - acpjournals.org
Chinese translation This article has been corrected. The original version (PDF) is appended
to this article as a Supplement . Background: Idiopathic pulmonary fibrosis (IPF) is …

Brain natriuretic peptide is a prognostic parameter in chronic lung disease

…, M Vogeser, C Neurohr, M Trautnitz, J Behr - American journal of …, 2006 - atsjournals.org
Rationale: The detection of pulmonary hypertension in patients with chronic lung disease
has prognostic implications. The brain natriuretic peptide (BNP) has been suggested as a …